FundedIQ
Biotechnology

TendoNova: Funding, Investors & Team (Sep 2026)

TendoNova is a medical device manufacturing company that specializes in developing tools for minimally invasive orthopedic procedures that can be performed under ultrasound guidance in the physicians. It provides clinicians with modalities that are customizable to the individual patients. The company provides doctors with modalities that are adaptable to specific patient needs without having to incur significant additional costs by delivering micro-invasive equipment meant to perform percutaneous tenotomy under ultrasound guidance in-office. The company was founded in 2017 by Roy Wallen in Atlanta, Georgia.

www.tendonova.com LinkedIn Atlanta, United States 1-10 employees
Total raised
$450k
Rounds
1
Latest
Undisclosed round
Aug 2022

TendoNova has raised $450k across 1 funding round on record, the most recent an undisclosed round of $450k announced in Aug 2022.

That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

TendoNova Company Profile and Key Stats

Total funding raised
$450k
across 1 round on record
Funding rounds on record
1
Latest funding round
Undisclosed round
$450k in Aug 2022
Employees
1-10
reported band
Headquarters
Atlanta, United States

Latest funding round on record: Aug 2022.

TendoNova Funding Rounds

Date
Round
Amount
Undisclosed round
$450k

TendoNova Founders and Leadership Team

Name
Role
Contact
Mark Samuels
CEO
Locked

Contact details for the TendoNova team: 1 of 1 has an email address on file.

Start 14-day free trial →

TendoNova Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,183
$8.0M
29,878
$7.5M

TendoNova's latest round of $450k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like TendoNova in Biotechnology and Atlanta

Companies Similar to TendoNova

SeqWell’s is a biotechnology company that specializes in the fields of gene sequencing and laboratory…

Undisclosed round $960k

DermaSensor’s mission is to save lives and healthcare costs by providing easy access to effective skin cancer…

Series B $4.0M

Solstice Oncology is a clinical stage immuno-oncology company

Series A $225M

Encoded Therapeutics is a developer of precision gene therapies intended to provide treatment for a broad…

Series F $275M

BrainChild Bio is a biotechnology company in the clinical stage that specializes in pediatric brain tumors.…

Series A $116M

Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…

Series B $65.5M

Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…

Seed $7.0M

ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…

Series C $10.0M

EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…

Series A $35.0M

Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…

Convertible Note $3.5M

Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…

Convertible Note $6.8M

XiltriX North America is an information technology company that specializes in monitoring, predictive…

Undisclosed round $3.0M

TendoNova Funding FAQs

What does TendoNova do?

TendoNova is a medical device manufacturing company that specializes in developing tools for minimally invasive orthopedic procedures that can be performed under ultrasound guidance in the physicians. It provides clinicians with modalities that are customizable to the individual patients. The company provides doctors with modalities that are adaptable to specific patient needs without having to incur significant additional costs by delivering micro-invasive equipment meant to perform percutaneous tenotomy under ultrasound guidance in-office. The company was founded in 2017 by Roy Wallen in Atlanta, Georgia.

How much funding has TendoNova raised?

TendoNova has raised $450k across 1 round on record. The most recent is an undisclosed round of $450k announced in Aug 2022.

When did TendoNova last raise funding?

TendoNova's most recent funding round on record is an undisclosed round of $450k, announced in Aug 2022.

Who is the CEO of TendoNova?

Mark Samuels is listed as CEO at TendoNova.

Where is TendoNova headquartered?

TendoNova is based in Atlanta, Georgia, United States.

How many employees does TendoNova have?

TendoNova is in the 1-10 employee band.

How does TendoNova's funding compare to other Biotechnology startups?

TendoNova's latest round of $450k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,183 tracked companies over the last two years.

About FundedIQ's TendoNova Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for TendoNova is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.